Current practices in laboratory monitoring of HIV infection
暂无分享,去创建一个
[1] W. Göhde,et al. Affordable CD4+ T‐cell counts on ‘single‐platform’ flow cytometers I. Primary CD4 gating , 2000, British journal of haematology.
[2] T. Quinn,et al. A manual bead assay for the determination of absolute CD4+ and CD8+ lymphocyte counts in human immunodeficiency virus-infected individuals , 1995, Clinical and diagnostic laboratory immunology.
[3] J M Taylor,et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, The New England journal of medicine.
[4] M. Bergeron,et al. Evolution of leukocyte immunophenotyping as influenced by the HIV/AIDS pandemic: a short history of the development of gating strategies for CD4+ T-cell enumeration. , 1997, Cytometry.
[5] R. Badaró,et al. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. , 2006, Journal of virological methods.
[6] N. Ford,et al. HIV viral load monitoring in resource-limited regions: optional or necessary? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] D. Covas,et al. Hematological abnormalities in HIV-infected patients. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[8] J. Michalek,et al. Immunological parameters in current and former US Air Force personnel. , 1993, Vaccine.
[9] I. Sanne,et al. Cost-Effectiveness of Alternative Strategies for Initiating and Monitoring Highly Active Antiretroviral Therapy in the Developing World , 2007, Journal of acquired immune deficiency syndromes.
[10] R. Steigbigel,et al. A comparison of the Coulter STKS, Coulter S+IV, and manual analysis of white blood cell differential counts in a human immunodeficiency virus-infected population. , 1993, American journal of clinical pathology.
[11] M. Peeters,et al. New and old complex recombinant HIV-1 strains among patients with primary infection in 1996–2006 in France: The French ANRS CO06 primo cohort study , 2008, Retrovirology.
[12] D. Ho,et al. Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy , 1999, Journal of Virology.
[13] L. Scott,et al. Fluorogenic LUX primer for quantitation of HIV-1 by real-time RT-PCR , 2006, Molecular biotechnology.
[14] B. Autran,et al. Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes. , 1992, Journal of immunological methods.
[15] Milton C Weinstein,et al. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. , 2006, The New England journal of medicine.
[16] G. Pan,et al. Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assay. , 2005, Journal of virological methods.
[17] Bruno Ledergerber,et al. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes , 2004, The Lancet.
[18] R. Pandey,et al. Lymphocyte immunophenotype reference ranges in healthy Indian adults: implications for management of HIV/AIDS in India. , 2004, Clinical immunology.
[19] C. Tinelli,et al. Predictors of Long-Term Immunological Outcome in Rebounding Patients on Protease Inhibitor-Based HAART After Initial Successful Virologic Suppression: Implications for Timing to Switch , 2003, HIV clinical trials.
[20] Richard A. Loftus,et al. Global cost modeling analysis of HIV-1 and HCV viral load assays , 2003, Expert review of pharmacoeconomics & outcomes research.
[21] D. Katzenstein,et al. Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. , 2008, Archives of internal medicine.
[22] G. N. Bazuaye,et al. Autoimmune hemolytic anemia in HIV-infected patients: a hospital based study. , 2008, Annals of African medicine.
[23] Á. Holguín,et al. Comparison of Three Different Commercial Methods for Measuring Plasma Viraemia in Patients Infected with Non-B HIV-1 Subtypes , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[24] J. Giorgi. Characterization of T Lymphocyte Subset Alterations by Flow Cytometry in HIV Disease , 1993, Annals of the New York Academy of Sciences.
[25] A. Breckenridge,et al. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. , 2010, Lancet.
[26] T. Flanigan,et al. Natural history of human immunodeficiency virus disease in southern India. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] F. Hecht,et al. Quantitative and Cost Comparison of Ultrasensitive Human Immunodeficiency Virus Type 1 RNA Viral Load Assays: Bayer bDNA Quantiplex Versions 3.0 and 2.0 and Roche PCR Amplicor Monitor Version 1.5 , 2000, Journal of Clinical Microbiology.
[28] F. González-Sastre,et al. The Predictive Value of Several Markers in the Progression to Acquired Immunodeficiency Syndrome , 1998, Clinical chemistry and laboratory medicine.
[29] H. Günthard,et al. HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. , 2003, Journal of acquired immune deficiency syndromes.
[30] J. Braun,et al. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes , 2003, AIDS.
[31] J. Malone,et al. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. , 1990, Journal of acquired immune deficiency syndromes.
[32] F. Brun-Vézinet,et al. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma , 1996, Journal of clinical microbiology.
[33] J. Vincelette,et al. Multicenter Comparison of Roche COBAS AMPLICOR MONITOR Version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex Version 3.0 for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma , 2000, Journal of Clinical Microbiology.
[34] Alimuddin Zumla,et al. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients , 2003, The Lancet.
[35] F. Hecht,et al. The Relation Between Symptoms, Viral Load, and Viral Load Set Point in Primary HIV Infection , 2007, Journal of acquired immune deficiency syndromes.
[36] Lesley E Scott,et al. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. , 2002, Cytometry.
[37] W. Blattner,et al. The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers , 1989, Journal of Clinical Immunology.
[38] L. Scott,et al. Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa. , 2005, Journal of virological methods.
[39] J. Temple,et al. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. , 2004, Journal of virological methods.
[40] A. Phillips,et al. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. , 1996, Genitourinary medicine.
[41] L. Ferradini,et al. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up. , 2004, AIDS.
[42] D. K. Benjamin,et al. Rational testing of the HIV-exposed infant. , 2001, Pediatrics.
[43] B. Poiesz,et al. Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. , 1999, The Pediatric infectious disease journal.
[44] J. Nicholson,et al. Evaluation of alternative CD4 technologies for the enumeration of CD4 lymphocytes. , 1994, Journal of immunological methods.
[45] Cathy A Petti,et al. Laboratory medicine in Africa: a barrier to effective health care. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] R. Paranjape,et al. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India. , 2000, The National medical journal of India.
[47] S. Hammer,et al. The challenge of HIV-1 subtype diversity. , 2008, The New England journal of medicine.
[48] L. Bacheler,et al. HIV drug resistance tests: an update on methods for calculating phenotypic fold change from a viral genotype. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] F. Simon,et al. Plasma RNA viral load in HIV-1 group O infection by real-time PCR. , 2005, Methods in molecular biology.
[50] John W. Mellors,et al. New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma , 2003, Journal of Clinical Microbiology.
[51] J. Nicholson,et al. CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three-color assay. , 1993, Cytometry.
[52] C. Rouzioux,et al. HIV-1 viral load testing cost in developing countries: what’s new? , 2007, Expert review of molecular diagnostics.
[53] V. Sreenivas,et al. Correlation of immune activation with HIV-1 RNA levels assayed by real-time RT-PCR in HIV-1 subtype C infected patients in Northern India. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[54] James Bethel,et al. Performance Characteristics of HIV-1 Culture and HIV-1 DNA and RNA Amplification Assays for Early Diagnosis of Perinatal HIV-1 Infection , 2003, Journal of acquired immune deficiency syndromes.
[55] P. Volberding,et al. Human immunodeficiency virus hematology. , 2003, Hematology. American Society of Hematology. Education Program.
[56] M. Giacomini,et al. A novel and innovative quantitative kinetic software for virological colorimetric assays. , 1998, Journal of virological methods.
[57] R. Gelman,et al. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3(+)4(+)%. , 2000, Cytometry.
[58] H. Nagaraja,et al. Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. , 1998, American journal of respiratory and critical care medicine.
[59] T. Leitner,et al. HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma , 2003, Journal of medical virology.
[60] R. Écochard,et al. HIV-1 Load Comparison Using Four Commercial Real-Time Assays , 2010, Journal of Clinical Microbiology.
[61] S. Kleinman,et al. Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. , 1988, Journal of immunology.
[62] T. Schaberg,et al. Lymphocyte Subsets in Peripheral Blood and Smoking Habits , 1997, Lung.
[63] C. Sabin,et al. Serum beta 2-microglobulin at HIV-1 seroconversion as a predictor of severe immunodeficiency during 10 years of followup. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[64] F. Goebel,et al. Serum neopterin levels as predictor of AIDS , 1988, Klinische Wochenschrift.
[65] S. Cantor,et al. Cost - Effectiveness Analysis, Extended Dominance, and Ethics , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.
[66] Claire DeCristofaro,et al. Anal Pap smears: Should we be doing them? , 2009, Journal of the American Academy of Nurse Practitioners.
[67] M. Aboud,et al. Clinical Utility of Genotypic Resistance Tests for HIV-1-Infected Patients with Low-Level Virological Failure , 2010, Journal of Clinical Microbiology.
[68] W. Owiredu,et al. Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART. , 2011, African health sciences.
[69] M. Hirsch,et al. Monitoring HIV treatment in developing countries , 2006, BMJ : British Medical Journal.
[70] M. Choong,et al. Influence of Race, Age and Sex on the Lymphocyte Subsets in Peripheral Blood of Healthy Malaysian Adults , 1995, Annals of clinical biochemistry.
[71] T. Leitner,et al. Improved HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma , 2005, Journal of medical virology.
[72] F. Chew,et al. Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood. , 1996, Cytometry.
[73] D. Fuchs,et al. An evaluation of low‐cost progression markers in HIV‐1 seropositive Zambians , 2000, HIV medicine.
[74] T. Flanigan,et al. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[75] George Janossy,et al. Affordable CD4(+) T-cell counts on 'single-platform' flow cytometers I. Primary CD4 gating. , 2000 .
[76] D. Burke,et al. Department of Army lymphocyte immunophenotyping quality assurance program. , 1989, Clinical immunology and immunopathology.
[77] D. Wolday,et al. Reverse transcriptase activity for quantitation of HIV‐1 subtype C in plasma: Relation to RNA copy number and CD4 T‐cell count , 2006, Journal of medical virology.
[78] H. Klinker,et al. The Role of Therapeutic Drug Monitoring in the Management of Patients With Human Immunodeficiency Virus Infection , 2011, Therapeutic drug monitoring.
[79] S. Hammer,et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[80] T. Sudarsanam,et al. Evidence for lower CD4+ T cell and higher viral load in asymptomatic HIV-1 infected individuals of India: implications for therapy initiation. , 2008, Indian journal of medical microbiology.
[81] P. Roques,et al. Plasma viral RNA assay in HIV-1 group O infection by real-time PCR. , 2003, Journal of virological methods.
[82] M R Loken,et al. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. , 1990, Cytometry.
[83] V. Soriano,et al. Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT , 2005, Journal of Clinical Microbiology.
[84] E. Acosta,et al. Therapeutic drug monitoring in the treatment of HIV-infection. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[85] S. Hammer,et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. , 2000, JAMA.
[86] R. Miller,et al. The optimal application of forward and ninety-degree light scatter in flow cytometry for the gating of mononuclear cells. , 1985, Cytometry.
[87] K. Anastos,et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. , 2003, Journal of the National Cancer Institute.
[88] M. Jesudason,et al. Correlation of CD4+ T-Cell Counts Estimated by an Immunocapture Technique (Capcellia) with Viral Loads in Human Immunodeficiency Virus-Seropositive Individuals , 2001, Clinical Diagnostic Laboratory Immunology.
[89] D. Kyle,et al. Flow cytometric immunophenotyping of lymphocyte subsets in samples that contain a high proportion of non-lymphoid cells. , 1994, Cytometry.
[90] A. Badley,et al. Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens. , 2002, Cytometry.
[91] Jaap Goudsmit,et al. One-Tube Real-Time Isothermal Amplification Assay To Identify and Distinguish Human Immunodeficiency Virus Type 1 Subtypes A, B, and C and Circulating Recombinant Forms AE and AG , 2001, Journal of Clinical Microbiology.
[92] Michael S Saag,et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. , 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[93] D. Quaglino,et al. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: Quantitative flow cytometric analysis , 2001, American journal of hematology.
[94] R. Walensky,et al. Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis , 2010, PLoS medicine.
[95] A. P. D. Ponce de Leon,et al. Surrogate markers of disease progression in HIV-infected children in Rio de Janeiro, Brazil. , 1999, Journal of tropical pediatrics.
[96] V. Sreenivas,et al. CDC staging based on absolute CD4 count and CD4 percentage in an HIV‐1‐infected Indian population: treatment implications , 2005, Clinical and experimental immunology.
[97] M. Majchrowicz. Beyond antiretroviral access: low-cost laboratory tests needed for the developing world. , 2003, AIDS.
[98] Robert Oelrichs,et al. Monitoring of human immunodeficiency virus infection in resource-constrained countries. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[99] R. Greenblatt,et al. Does patient sex affect human immunodeficiency virus levels? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[100] W. S. Clark,et al. Clinical Comparison of an Enhanced-Sensitivity Branched-DNA Assay and Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma , 1998, Journal of Clinical Microbiology.
[101] P. Ghys,et al. Comparison of NucliSens and Amplicor Monitor Assays for Quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Plasma of Persons with HIV-1 Subtype A Infection in Abidjan, Côte d’Ivoire , 1998, Journal of Clinical Microbiology.
[102] David Bishai,et al. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings , 2007, AIDS.
[103] Deenan Pillay,et al. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model , 2008, The Lancet.
[104] K. Mayer,et al. Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries. , 2005, The Indian journal of medical research.
[105] D. Torre,et al. Platelets and HIV-1 infection: old and new aspects. , 2008, Current HIV research.
[106] J. Moskowitz,et al. Pediatric HIV Costs Across Three Treatment Eras From 1986 to 2007 , 2010, Pediatrics.
[107] J. Hocking,et al. Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring. , 2005, Current HIV research.
[108] Xavier Anglaret,et al. Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting , 2005, Journal of Clinical Microbiology.
[109] J. Fahey,et al. Distinct categories of immunologic changes in frail elderly , 2000, Mechanisms of Ageing and Development.
[110] C. Gilks,et al. Cost Effectiveness Analysis of Routine Laboratory or Clinically Driven Strategies for Monitoring Anti-Retroviral Therapy in Uganda and Zimbabwe (DART Trial) , 2009 .
[111] Christopher D. Pilcher,et al. Comparison of NucliSens and Roche Monitor Assays for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma , 1999, Journal of Clinical Microbiology.
[112] Lesley Scott,et al. Performance of the New Roche Cobas AmpliPrep-Cobas TaqMan Version 2.0 Human Immunodeficiency Virus Type 1 Assay , 2009, Journal of Clinical Microbiology.
[113] R. Holzman,et al. Human Immunodeficiency Virus (HIV) Reverse Transcriptase Activity Correlates with HIV RNA Load: Implications for Resource-Limited Settings , 2005, Journal of Clinical Microbiology.
[114] M. Kalish,et al. Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. Perinatal AIDS Collaborative Transmission Study. , 1998, AIDS.
[115] N. Shaffer,et al. Early Diagnosis of HIV‐1‐Infected Infants in Thailand Using RNA and DNA PCR Assays Sensitive to Non‐B Subtypes , 2000, Journal of acquired immune deficiency syndromes.
[116] F. Heinz,et al. Comparison of virtual phenotype and HIV‐SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains , 2002, HIV medicine.
[117] T. Wrin,et al. CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy. , 2002, The Journal of infectious diseases.
[118] Michael J Silverberg,et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. , 2009, The New England journal of medicine.
[119] G. Cordero. [HIV infection]. , 1995, SIDAhora : un proyecto del Departamento de Publicaciones del PWA Coalition, NY.
[120] Kenneth H Mayer,et al. An Inexpensive, Simple, and Manual Method of CD4 T-Cell Quantitation in HIV-Infected Individuals for Use in Developing Countries , 2004, Journal of acquired immune deficiency syndromes.
[121] J M Taylor,et al. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. , 1989, Journal of acquired immune deficiency syndromes.
[122] F. Samuels,et al. Population mobility and HIV and AIDS: review of laws, policies and treaties between Bangladesh, Nepal and India , 2011 .
[123] Lei Wang,et al. Association of HIV Diversity and Survival in HIV-Infected Ugandan Infants , 2011, PloS one.
[124] D. Costagliola,et al. Modeling the Time Course of CD4 T-Lymphocyte Counts According to the Level of Virologic Rebound in HIV-1–Infected Patients on Highly Active Antiretroviral Therapy , 2003, Journal of acquired immune deficiency syndromes.
[125] S S Uppal,et al. Normal values of CD4 and CD8 lymphocyte subsets in healthy indian adults and the effects of sex, age, ethnicity, and smoking , 2003, Cytometry. Part B, Clinical cytometry.